Leyden Labs
Mucosal Immunity
2 open rolesMucosal ImmunityLeiden, Netherlands91 employees$257M raisedEst. 2020
GV
Casdin Capital
F-Prime Capital
SoftBank Vision Fund 2
Invus
Bluebird Ventures
About Leyden Labs
- Leyden Labs is a clinical-stage biotech company developing products, specifically nasal sprays containing antibodies, that leverage mucosal immunity to protect humanity from known and future respiratory viruses.
- Their platform targets commonalities of viral families to help people live freely.
Leyden Labs is listed on Rocketlist with 2 active roles. The company is categorized as Mucosal Immunity in BioTech. Leyden Labs is at Series B stage, with a B2B and B2C business model, headquartered in Leiden, Netherlands. Leyden Labs was founded in 2020 and has 91 employees. Leyden Labs has raised $257M. Active roles are refreshed daily from public hiring sources.